Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EYPT

EyePoint

$2.28

-0.03 (-1.30%)

07:47
09/13/18
09/13
07:47
09/13/18
07:47
Recommendations
EyePoint analyst commentary at H.C. Wainwright »

EyePoint price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

EYPT

EyePoint

$2.31

0.115 (5.25%)

06:09
09/12/18
09/12
06:09
09/12/18
06:09
Earnings
EyePoint reports Q4 EPS (62c), consensus (11c) »

Reports Q4 revenue $715K,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

EYPT

EyePoint

$2.12

-0.08 (-3.64%)

17:24
09/05/18
09/05
17:24
09/05/18
17:24
Hot Stocks
EyePoint jumps 8.5% after CMS approves C-code for DEXYCUTM »

EyePoint Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

Over a month ago
EYPT

EyePoint

$2.28

0.01 (0.44%)

07:14
08/01/18
08/01
07:14
08/01/18
07:14
Hot Stocks
EyePoint appoints David Price as CFO »

EyePoint Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYPT

EyePoint

$2.43

0.16 (7.05%)

17:30
07/25/18
07/25
17:30
07/25/18
17:30
Syndicate
Breaking Syndicate news story on EyePoint »

EyePoint files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYPT

EyePoint

$2.43

0.16 (7.05%)

17:09
07/25/18
07/25
17:09
07/25/18
17:09
Hot Stocks
EyePoint presents data highlighting YUTIQ for posterior segment uveitis »

EyePoint Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
EYPT

EyePoint

$1.98

0.03 (1.54%)

07:14
06/25/18
06/25
07:14
06/25/18
07:14
Hot Stocks
EyePoint receives stockholder approval of second tranche of capital financing »

EyePoint Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYPT

EyePoint

$2.09

0.15 (7.73%)

04:55
05/25/18
05/25
04:55
05/25/18
04:55
Conference/Events
EyePoint management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

EYPT

EyePoint

$1.94

(0.00%)

09:22
05/24/18
05/24
09:22
05/24/18
09:22
Conference/Events
EyePoint management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

EYPT

EyePoint

$2.34

-0.04 (-1.68%)

16:39
05/08/18
05/08
16:39
05/08/18
16:39
Earnings
EyePoint reports Q3 EPS (15c), consensus (13c) »

Reports Q3 revenue $928K,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.